Retraction: Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells (Int J Oncol (2010) 36 (665-672) DOI: 10.3892/ijo_00000542);Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells

International Journal of Oncology

Volumn 36, Issue 3, 2010, Pages 665-672

  Zhou, Xuan ^a,b   Ren, Yu ^b   Han, Lei ^a   Mei, Mei ^b   Xu, Peng ^a   Zhang, Chun Zhi ^a   Wang, Guang Xiu ^a   Jia, Zhi Fan ^a   Pu, Pei Yu ^a,b   Kang, Chun Sheng ^a,b  

^a Tian Jin Normal University   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

AKT pathway; c Myc; Glioma; microRNA; miR 21; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; PROTEIN KINASE B; SMALL INTERFERING RNA; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; BINDING SITE; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; BRAIN NEOPLASMS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GLIOMA; METABOLISM; TUMOR CELL LINE;

BINDING SITES; BRAIN NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLIOMA; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 77149127370     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2023.5597     Document Type: Erratum

References (47)

1. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359: 1011-1018, 2002.
2. Testa JR and Bellacosa A: AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98: 10983-10985, 2001.
3. Vivanco I and Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002.
4. McLendon RE, Turner K, Perkinson K and Rich J: Second messenger systems in human gliomas. Arch Pathol Lab Med 131: 1585-1590, 2007.
5. Pu PY, Kang CS, Li J, Jiang H and Cheng JQ: The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo. J Neurooncol 76: 1-11, 2006.
6. Pu PY, Kang CS, Li J and Jiang H: Antisense and dominantnegative AKT2 cDNA inhibits glioma cell invasion. Tumor Biol 25: 172-178, 2004.
7. Lee RC and Ambros V: An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864, 2001.
8. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
9. He L, He X, Lim LP, et al: A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134, 2007.
10. He X, He L and Hannon GJ: The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67: 11099-11101, 2007.
11. Hermeking H: p53 enters the microRNA world. Cancer Cell 12: 414-418, 2007.
12. Xi Y, Shalgi R, Fodstad O, Pilpel Y and Ju J: Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12: 2014-2024, 2006.
13. Zhang X, Jin B and Huang C: The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. Curr Cancer Drug Targets 7: 305-316, 2007.
14. Taganov KD, Boldin MP, Chang KJ and Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486, 2006.
15. Schulte JH, Horn S, Otto T, et al: MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int J Cancer 122: 699-704, 2008.
16. Sampson VB, Rong NH, Han J, et al: MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67: 9762-9770, 2007.
17. De la Iglesia N, Konopka G, Puram SV, et al: Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 22: 449-462, 2008.
18. Löffler D, Brocke-Heidrich K, Pfeifer G, et al: Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333, 2007.
19. Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y and Patel T: The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem 282: 8256-8264, 2007.
20. Krichevsky AM, Sonntag KC, Isacson O and Kosik KS: Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24: 857-864, 2006.
21. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007.
22. Bolstad BM, Irizarry RA, Astrandand M and Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193, 2003.
23. Kang CS, Zhang ZY, Jia ZF, et al: Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 13: 530-538, 2006.
24. Kane LP, Shapiro VS, Stokoe D and Weiss A: Induction of NF-κB by the Akt/PKB kinase. Curr Biol 9: 601-604, 1999.
25. Madrid LV, Mayo MW, Reuther JY and Baldwin AS Jr: Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940, 2001.
26. Segrelles C, Moral M, Lara MF, Ruiz S, Santos M, Leis H, García-Escudero R, Martínez-Cruz AB, Martínez-Palacio J, Hernández P, Ballestín C and Paramio JM: Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 25: 1174-1185, 2006.
27. John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS: Human microRNA targets. PLoS Biol 2: E363, 2004.
28. Ramkissoon SH, Mainwaring LA, Sloand EM, Young NS and Kajigaya S: Nonisotopic detection of microRNA using digoxigenin labeled RNA probes. Mol Cell Probes 20: 1-4, 2006.
29. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006.
30. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005.
31. Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY: MiR-21-mediated tumor growth. Oncogene 26: 2799-2803, 2007.
32. Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336, 2007.
33. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS and Krichevsky AM: MiR-21 promotes glioma invasion by targeting MMP regulators. Mol Cell Biol 28: 5369-5380, 2008.
34. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R and Shah K: MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67: 8994-9000, 2007.
35. Chan JA, Krichevsky AM and Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005.
36. Ciafrè SA, Galardi S, Mangiola A, et al: Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358, 2005.
37. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF and Wong N: MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135: 257-269, 2008.
38. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP and Wei WI: Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588-2592, 2008.
39. Slaby O, Svoboda M, Fabian P, et al: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007.
40. Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ: MiRBase: tools for microRNA genomics. Nucleic Acids Res 36: 154-158, 2008.
41. Yang H, Kong W, He L, et al: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433, 2008.
42. Iyer VR, Eisen MB, Ross DT, et al: The transcriptional program in the response of human fibroblasts to serum. Science 283: 83-87, 1999.
43. Gu J and Iyer VR: PI3K signaling and miRNA expression during the response of quiescent human fibroblasts to distinct proliferative stimuli. Genome Biol 7: R42, 2006.
44. Hornstein E and Shomron N: Canalization of development by microRNAs. Nat Genet 38 (Suppl): S20-S24, 2006.
45. Shalgi R, Lieber D, Oren M and Pilpel Y: Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3: E131, 2007.
46. Matys V, Fricke E, Geffers R, et al: TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31: 374-378, 2003.
47. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV and Wingender E: MATCHTM: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 31: 3576-3579, 2003.